Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Item

http://www.wikidata.org/entity/Q47789478

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@en

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@nl

type

Item

label

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@en

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@nl

prefLabel

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@en

Prospective Quality of Life St ...... Intraperitoneal Chemotherapy.

@nl

P1476

Prospective Quality of Life St ...... c Intraperitoneal Chemotherapy

@en

P2093

Claramae Shulyn Chia

http://www.w3.org/2001/XMLSchema#string

Grace Hwei Ching Tan

http://www.w3.org/2001/XMLSchema#string

Khee Chee Soo

http://www.w3.org/2001/XMLSchema#string

Melissa Ching Ching Teo

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.

Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution.

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.

Summary scores captured changes in subjects' QoL as measured by the multiple scales of the EORTC QLQ-C30.

Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

P2888

s10434-016-5203-6

P304

2905-2913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-016-5203-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cindy Lim

P577

2016-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1051348150

http://www.w3.org/2001/XMLSchema#string

P698

27016293

http://www.w3.org/2001/XMLSchema#string

P921

quality of life

colorectal cancer